Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Radius Health (NQ: RDUS )

10.50 +0.32 (+3.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,928,398
Open 10.15
Bid (Size) 10.46 (1)
Ask (Size) 10.60 (2)
Prev. Close 10.18
Today's Range 10.11 - 10.52
52wk Range 4.970 - 23.00
Shares Outstanding 47,266,146
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Short Volatility Alert: Radius Health, Inc.
On Monday, shares of Radius Health, Inc. (NASDAQ: RDUS) experienced volatile short activity. After the activity, the stock price went up +0.69% to $10.18. The overall sentiment for RDUS has been... 
Via Benzinga
4 Analysts Have This to Say About Radius Health
Analysts have provided the following ratings for Radius Health (NASDAQ:RDUS) within the last quarter: 
Via Benzinga

Performance

YTD
+51.52%
+51.52%
1 Month
+65.88%
+65.88%
3 Month
+12.42%
+12.42%
6 Month
+54.41%
+54.41%
1 Year
-46.62%
-46.62%

More News

Read More
Velan-Repertoire Comments on Proposed Sale of Radius Health to Gurnet Point Capital and Patient Square Capital
From Velan Capital Investment Management LP and Repertoire Partners LP
Via Business Wire
RADIUS HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Radius Health, Inc. - RDUS
From Kahn Swick & Foti, LLC
Via Business Wire
Bone Health Focused Radius Health Goes Private In $890M Deal
Via Benzinga
Recap: Radius Health Q1 Earnings
Via Benzinga
Mosaic Tumbles Around 10%, Here's 71 Biggest Movers From Yesterday
Via Benzinga
RDUS Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Radius Health, Inc. Is Fair to Shareholders
From Halper Sadeh LLP
Via Business Wire
The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise
Via Benzinga
Velan-Repertoire Releases Detailed Presentation on the Need for Board Change at Radius Health and Sends Letter to Stockholders
From Velan Capital Investment Management LP and Repertoire Partners LP
Via Business Wire
Rubric Capital Management Sends Letter to Radius Health Board of Directors
From Rubric Capital Management LP
Via Business Wire
63 Biggest Movers From Yesterday
Via Benzinga
Velan-Repertoire Responds to Misleading Characterizations by the Radius Board
From Velan-Repertoire Group
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 8, 2022
Via Benzinga
Velan-Repertoire Group Files Definitive Proxy Materials in Connection With Radius Health 2022 Annual Meeting
From Velan-Repertoire Group
Via Business Wire
Radius Health's Return On Capital Employed Insights
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
Via Benzinga
Menarini, Radius Health's Elacestrant Prolongs Progression Free Survival In Breast Cancer
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
How To Attend Radius Health Q1 2022 Earnings Conference Call
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
FDA Approves Update On Radius Health's Tymlos label
Via Benzinga
4 Stocks Insiders Are Buying
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.